These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 29018913)

  • 1. Meeting report of the 8
    Friebe A; Sandner P; Schmidtko A
    Naunyn Schmiedebergs Arch Pharmacol; 2017 Dec; 390(12):1177-1188. PubMed ID: 29018913
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The 10th International Conference on cGMP 2022: recent trends in cGMP research and development-meeting report.
    Friebe A; Kraehling JR; Russwurm M; Sandner P; Schmidtko A
    Naunyn Schmiedebergs Arch Pharmacol; 2023 Aug; 396(8):1669-1686. PubMed ID: 37079081
    [TBL] [Abstract][Full Text] [Related]  

  • 3. From bedside to bench--meeting report of the 7th International Conference on cGMP "cGMP: generators, effectors and therapeutic implications" in Trier, Germany, from June 19th to 21st 2015.
    Friebe A; Sandner P; Seifert R
    Naunyn Schmiedebergs Arch Pharmacol; 2015 Dec; 388(12):1237-46. PubMed ID: 26486926
    [TBL] [Abstract][Full Text] [Related]  

  • 4. cGMP: transition from bench to bedside: a report of the 6th International Conference on cGMP Generators, Effectors and Therapeutic Implications.
    Hoffmann LS; Chen HH
    Naunyn Schmiedebergs Arch Pharmacol; 2014 Aug; 387(8):707-18. PubMed ID: 24927824
    [TBL] [Abstract][Full Text] [Related]  

  • 5. cGMP: a unique 2nd messenger molecule - recent developments in cGMP research and development.
    Friebe A; Sandner P; Schmidtko A
    Naunyn Schmiedebergs Arch Pharmacol; 2020 Feb; 393(2):287-302. PubMed ID: 31853617
    [TBL] [Abstract][Full Text] [Related]  

  • 6. cGMP becomes a drug target.
    Schlossmann J; Schinner E
    Naunyn Schmiedebergs Arch Pharmacol; 2012 Mar; 385(3):243-52. PubMed ID: 22297800
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiovascular cGMP-generating systems in physiological and pathological conditions.
    Cerra MC; Pellegrino D
    Curr Med Chem; 2007; 14(5):585-99. PubMed ID: 17346149
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Guanylyl cyclases, nitric oxide, natriuretic peptides, and airway smooth muscle function.
    Hamad AM; Clayton A; Islam B; Knox AJ
    Am J Physiol Lung Cell Mol Physiol; 2003 Nov; 285(5):L973-83. PubMed ID: 14551038
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential relaxing responses to particulate or soluble guanylyl cyclase activation on endothelial cells: a mechanism dependent on PKG-I alpha activation by NO/cGMP.
    Rivero-Vilches FJ; de Frutos S; Saura M; Rodriguez-Puyol D; Rodriguez-Puyol M
    Am J Physiol Cell Physiol; 2003 Oct; 285(4):C891-8. PubMed ID: 12814915
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Meeting report: cGMP matters.
    Kemp-Harper B; Feil R
    Sci Signal; 2008 Mar; 1(9):pe12. PubMed ID: 18319447
    [TBL] [Abstract][Full Text] [Related]  

  • 11. What is next in nitric oxide research? From cardiovascular system to cancer biology.
    Bian K; Murad F
    Nitric Oxide; 2014 Dec; 43():3-7. PubMed ID: 25153032
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Natriuretic peptides and nitric oxide stimulate cGMP synthesis in different cellular compartments.
    Piggott LA; Hassell KA; Berkova Z; Morris AP; Silberbach M; Rich TC
    J Gen Physiol; 2006 Jul; 128(1):3-14. PubMed ID: 16769793
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Soluble Guanylate Cyclase Stimulators and Activators.
    Sandner P; Zimmer DP; Milne GT; Follmann M; Hobbs A; Stasch JP
    Handb Exp Pharmacol; 2021; 264():355-394. PubMed ID: 30689085
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of the nitric oxide-soluble guanylyl cyclase pathway in obstructive airway diseases.
    Dupont LL; Glynos C; Bracke KR; Brouckaert P; Brusselle GG
    Pulm Pharmacol Ther; 2014 Oct; 29(1):1-6. PubMed ID: 25043200
    [TBL] [Abstract][Full Text] [Related]  

  • 15. sGC-cGMP signaling: target for anticancer therapy.
    Bian K; Murad F
    Adv Exp Med Biol; 2014; 814():5-13. PubMed ID: 25015797
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of endogenous nitric oxide synthesis activates particulate guanylyl cyclase in the rat renal glomeruli.
    Lewko B; Wendt U; Szczepanska-Konkel M; Stepinski J; Drewnowska K; Angielski S
    Kidney Int; 1997 Sep; 52(3):654-9. PubMed ID: 9291184
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Traumatic injury of the spinal cord and nitric oxide.
    Marsala J; Orendácová J; Lukácová N; Vanický I
    Prog Brain Res; 2007; 161():171-83. PubMed ID: 17618976
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of ischemia on soluble and particulate guanylyl cyclase-mediated cGMP synthesis in cardiomyocytes.
    Agulló L; Garcia-Dorado D; Escalona N; Ruiz-Meana M; Inserte J; Soler-Soler J
    Am J Physiol Heart Circ Physiol; 2003 Jun; 284(6):H2170-6. PubMed ID: 12586638
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cyclic GMP as a second messenger in the cardiovascular system.
    Imai S
    Jpn Heart J; 1995 Mar; 36(2):127-77. PubMed ID: 7596037
    [TBL] [Abstract][Full Text] [Related]  

  • 20. C-type natriuretic peptide decreases soluble guanylate cyclase levels by activating the proteasome pathway.
    de Frutos S; Saura M; Rivero-Vilches FJ; Rodriguez-Puyol D; Rodriguez-Puyol M
    Biochim Biophys Acta; 2003 Dec; 1643(1-3):105-12. PubMed ID: 14654233
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.